In order to clarify the metallothionein (MT) localization in the developing placenta, we histologically investigated the sequential MT expression in placentas and fetal livers using pregnant rats during gestation days (GDs) 9 -21. The placentas were sampled and weighed on GDs 9, 11, 13, 15, 17, 19 and 21. In the early post implantation period, the expression of MT was slightly detected in the yolk sac and the primary decidual zone around the embryo. MT was then mainly present in the deciduas parietalis and yolk sac. After the deciduas parietalis ruptured, MT was subsequently detected in the yolk sac and deciduas basalis. MT continued to be detected in the yolk sac until GD 21, but it was reduced in the deciduas basalis in accordance with development of the fetal liver with elevated MT expression. In conclusion, the main expression site of MT changes from the maternal placenta to the fetal placenta, and then to the fetal liver in accordance with the fetal development. However, we speculate that the MT-positive cells in the placenta are positioned between the maternal and embryonic environments throughout the gestation period and always surround the embryo/fetus. (J Toxicol Pathol 2008; 21: 223-227) 
Introduction
Metallothionein (MT) is a family of cysteine-rich, low molecular weight (MW: 3500 to 14000 Da) metalloproteins that have high affinity for several divalent metals, such as cadmium, zinc, mercury and copper. MT is expressed to a certain extent in almost all mammalian tissues. MT plays a role in the homeostasis of zinc and copper, and also provides protection from the toxic effects of cadmium and mercury. MT has been extensively studied in relation to cadmium toxicity and has been shown to play an important role in the toxicokinetics of cadmium 1 . The placenta plays a major role in the transfer of O 2 / CO 2 and nutrient/metabolite requirements from the dam to the embryo and also in protecting the embryo from toxic compounds during mammalian fetal development. Both zinc and copper are essential metals for growth and development of the fetus. Placental MT can be considered to regulate metal transport of these metals from maternal to fetal blood 2 . On the other hand, cadmium is known to accumulate in the placenta and induces cellular damage, which can result in teratogenic or embryotoxic effects 3 . The placental transfer of cadmium has been studied in the rat 4 , mouse 5 , rabbit 6 and human 7 . The placenta is thought to protect the developing embryo/fetus from this toxic metal mechanism by which placental MT restricts entry of cadmium into the embryonic environment. However, there have been no reports on the sequential morphological details of MT expression in the rat placenta. In order to clarify the M T l o c a l iz a t io n in t h e d e v e l op in g p la c e n ta , we histologically investigated the sequential MT expression in placentas and fetal livers in normal rats during gestation days (GDs) 9 -21.
Materials and Methods

Animals
A total of 28 pregnant, specific-pathogen-free Wistar Hannover GALAS rats (CLEA Japan, Inc., Japan) approximately 10 -14 weeks of age were purchased for use in the present study. The animals were housed individually in wire mesh cages in an air-conditioned room (22 ± 2°C; humidity, 55 ± 10%; light cycle, 12 hr/day). Feed (Oriental Yeast Co., Ltd., Japan) and water were available ad libitum.
Experimental design
GD 0 was designated as the day when the presence of a vaginal plug was identified. Four maternal rats were sampled on GDs 9, 11, 13, 15, 17, 19 and 21. Dams were euthanized by exsanguination under anesthesia and necropsied. All embryos/fetuses and half of the placentas were removed from each uterus and weighed. The placentas and embryos/fetuses were fixed in 10% neutral buffered formalin. This experiment was conducted according to the Guidelines for Animal Experimentation, Japanese Association for Laboratory Animal Science, 1987.
Histopathological examination
Four placentas that were not removed from the uterus of each dam at each sampling, and four fetal livers from each dam during GDs 13 -21 were embedded in paraffin, sectioned at a 4-µm thickness and stained routinely with hematoxylin and eosin (H&E). Immunohistochemical staining using an antibody against rat MT-1 and MT-2 (MT E9, Dako Cytomation, USA) was performed on these tissues according to the avidin-biotin complex (ABC) method (VECTSTAIN ABC Kit, Vector Laboratories Inc., Canada). Table 1 shows the total numbers and weights of the live embryos/fetuses, the dead embryo/fetus ratio and the placenta weights at each sampling time point. Table  2 and Fig. 1 show the sequential changes in the immunohistochemical MT expression in the placenta, fetal liver and uterus.
Results
Yolk sac
On GD 9, minimal staining of MT was detected in the cytoplasm of epithelial in the visceral yolk sac (Fig. 1a2) . After the embryo turned and the yolk sac covered the entire embryo, the intensity of positive staining with MT in the yolk sac gradually increased until GD 19 (Figs. 1b2, c2, d2) and then slightly decreased on GD 21 (Fig. 1e2) . MT staining was prominent at the free surface of the epithelial cells.
Labyrinth and basal zones
A few MT-positive spongiotrophoblasts in the basal zone were detected during GDs 15 -21, although there was no MT staining in the glycogen cells or giant cells in the basal zone or in the trophoblasts in the labyrinth zone throughout the gestation period (Figs. 1b1, c1, d1, e1) .
Decidua
On GD 9, MT was detected in the cytoplasm and nuclei of decidual cells in the primary decidual zone around the embryo (Fig. 1a1) . In addition, there were a few MTpositive cells scattered in the secondary decidual zone. On GD 11, MT was more prominent in the deciduas parietalis than in the deciduas basalis (Fig. 1b1) . After GD 13, MT staining was observed in the decidual cells in the deciduas basalis beneath the basal zone (Figs. 1c1, c3) . The intensity of positive staining with MT in the deciduas basalis increased until GD 15 and then decreased with the progress of placental development (Figs. 1d1, d3, e1, e3).
Fetal liver
MT was detected mainly in the cytoplasm and nuclei of hepatocytes beginning on GD 15 (Figs. 1c4, d4 ). The intensity of positive staining with MT gradually increased with the progress of fetal development, and reached the maximum level on GD 21 (Fig. 1e4) .
Uterus
Strong expression of MT was detected in the uterine glandular epithelium throughout the gestation period.
Discussion
MTs consist of four major groups (MT-1, MT-2, MT-3 and MT-4), and the most well-studied MTs are mammalian MT-1 and MT-2. MT-1 is present with MT-2 and is expressed in almost all tissues 1 . In the present study, immnohistochemical sequential MT-1 and MT-2 expression was cell-specifically examined in placentas and fetal livers using normal pregnant rats. We found that MT was mainly present in the decidua and yolk sac in the placenta and in the fetal liver. MT can avidly sequester intracellular essential metals such as zinc and copper and also provide protection from the toxic effects of cadmium and mercury during pregnancy 8, 9 . Normal pregnant rats have higher plasma cadmium levels and MT levels compared with non-pregnant rats 10 , and the basal levels of MT already increased on GD 8 in pregnant rats 11 . It is likely that maternal plasma MT originates in the liver 12 . On the other hand, MT is also detected in the fetal liver and placenta during pregnancy in rats 4, 9 . Both zinc and copper are found at high concentrations in the human and rodent fetal liver bound to MT during the perinatal development 2 . In the rat fetal liver, MT is present on GD 16, and the MT level continues to increase into the neonatal period as determined by an enzyme-linked immunosorbent assay 13 . In the human placenta obtained from full-term healthy infants, MT has been immunohistochemically identified in amniotic cells, syncytial trophoblasts, villous interstitial cells and decidual cells 2 . In the mouse placenta, cell-specific expression of MT genes occurs in the yolk sac, spongiotrophoblasts and decidual cells throughout the gestation period 14 .
In the present study, the MT location in the normal developing rat placenta was almost the same as shown in mice. In development of the rat placenta, the yolk sac is bilaminar, and is composed of trophoblast and a single layer of hypoblast (endodermal cells) in the early post implantation period. When the yolk sac surrounds the early embryo as a double-layer sac, the yolk sac placenta begins to transfer substances and nutrition from the dam to the embryo. In this period, MT was slightly detected in the yolk sac and primary decidual zone around the embryo. The expression of MT then mainly increased in the yolk sac and deciduas parietalis. After the chorioallantoic placenta began to function and deciduas parietalis ruptured, MT was subsequently detected in the yolk sac and the deciduas basalis. The rodent yolk sac is largely responsible for providing amino acid nutrition to the early post-implantation embryo and possibly also in the late fetal stage of gestation, unlike other mammalian placentas 15 . In the present study, MT continued to be detected in the yolk sac until GD 21, and it seems that the yolk sac in rats might also be involved in homeostasis of essential and toxic metals until birth. In contrast, the expression of MT gradually decreased in the deciduas basalis, but increased in the fetal liver in accordance with the fetal development. Therefore, the main expression site of MT changes from the maternal placenta to the fetal placenta and then to the fetal liver in accordance with the fetal development. However, we speculate that the MT-positive cells in the placenta are positioned between the maternal and embryonic environments throughout the gestation period and always surround the embryo/fetus for homeostasis of essential metals and protection from metal toxic effects. We suppose that MT may play an important role in embryonic development and maintenance of normal pregnancy.
